Recorded device evidence

COVIDIEN WARMTOUCH CONVECTIVE WARMING UNIT (K123083): indications, design and recorded evidence

The acquired K123083 file contains product-specific indications and users, design and operating principle, performance evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-08. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 15 selected decisions under primary code DWJ. 15 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

No quartiles are displayed: this complete-year cohort has fewer than 20 valid pairs.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K123083 ↗ · this pageCOVIDIEN WARMTOUCH CONVECTIVE WARMING UNIT2012-10-01 → 2013-04-17198Traditional
K262089 ↗Disposable Warming Blanket2026-06-22 → 2026-08-2160Traditional
K261437 ↗Mistral-Air® Warming System2026-04-30 → 2026-08-0799Special
K260278 ↗ThermAffyx(TM) Patient Safety System2026-01-29 → 2026-07-08160Traditional
K260903 ↗Hot Pink Pad Warming System2026-03-18 → 2026-04-1629Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K123083 · PDF page 3 ↗ Source 2

The        WarmTouch TM               Convective       Warming              Unit        is a portable           device     that      is used         in
conjunction         with       a WarmTouch TM              Blanket         as       a system          that      is intended        for         prescription
use.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Design and operating principle

K123083 · PDF page 2 ↗ Source 3

The          WarmTouchTM                 Convective        Warming             Unit      is      an           electro-mechanical           blower      that
      delivers     heated          air.                    The     WarmTouchM"       Convective        Warming              Unit        is     part         of the
      WarmTouch TM              Convective        Warming              System      that       consists     of the      blower     warming          unit
      and        Covidien's        WarmTouchTM                    Blankets.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

Performance evidence actually described

K123083 · PDF page 3 ↗ Source 2

The        design        of  the      WarmTouch TM                 Convective     Warming              Unit        features     the        same           ambient
blower        operating        range       and            air  flow      rate       as       the        predicate       device.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK123083 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryCOVIDIEN WARMTOUCH CONVECTIVE WARMING UNIT [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantCovidien [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeDWJ [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2013-04-17 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2012-10-01 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Design and operating principle — what differs in our product?

    Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

    Useful evidence: Design description, materials/components, accessory list and a differences matrix.

  3. Performance evidence actually described — what differs in our product?

    The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

    Useful evidence: The cited narrative and full tables, underlying protocols/results and a reviewed comparison with the proposed product.

Work packages and dependencies

What needs to happen first

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[70409] · record 0a0a69f4ef5562ced103e2eaf2ba52828d513fb8e6e25a996089f17f9e947d4b
  • [4] Complete results array / fda-decision-context:K123083 · record whole dataset partition

FDA 510(k) summary — K123083 ↗

Mon, 06 May 2013 15:19:34 GMT · retrieved 2026-10-08

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot 2196ca5be1f1c901919594eb98ecc15e0fdd208fc48cd1a277734ad8411d8252

  • [2] PDF page 3 · record bae8def3f860ac714daeeae93aee466b7bceee979a6df61bab737207e6408db4
  • [3] PDF page 2 · record a7b97864668761b4800d0090ccf9f66dc1de810cc9c224a5ef67e0a05c31deb3

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services

Usability / Human Factors Testing